Stephen Dow

Steve Dow, a general partner at Sevin Rosen Funds since 1983, has been an advisor to entrepreneurs building companies in a wide variety of markets and technologies. In addition to board appointments at Limerick and private companies Alder Pharmaceuticals, Kabira, OpenClovis, and RNT, Mr. Dow serves on the boards of two public companies, Citrix (CTXS) and Cytokinetics (CYTK). In both of these public companies, he helped incubate them and had been involved in the early formation of their initial business plans. Mr. Dow has a BA and an MBA from Stanford University.